BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 16198159)

  • 1. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
    Chong YP; Ia KK; Mulhern TD; Cheng HC
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
    Chong YP; Mulhern TD; Cheng HC
    Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
    Chong YP; Chan AS; Chan KC; Williamson NA; Lerner EC; Smithgall TE; Bjorge JD; Fujita DJ; Purcell AW; Scholz G; Mulhern TD; Cheng HC
    J Biol Chem; 2006 Nov; 281(44):32988-99. PubMed ID: 16959780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
    Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
    Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity.
    Chong YP; Mulhern TD; Zhu HJ; Fujita DJ; Bjorge JD; Tantiongco JP; Sotirellis N; Lio DS; Scholz G; Cheng HC
    J Biol Chem; 2004 May; 279(20):20752-66. PubMed ID: 14985335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
    Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
    Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric networks governing regulation and catalysis of Src-family protein tyrosine kinases: implications for disease-associated kinases.
    Cheng HC; Johnson TM; Mills RD; Chong YP; Chan KC; Culvenor JG
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):93-101. PubMed ID: 19566834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
    Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
    Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
    Maruyama T; Yamamoto Y; Shimizu A; Masuda H; Sakai N; Sakurai R; Asada H; Yoshimura Y
    Biol Reprod; 2004 Jan; 70(1):214-21. PubMed ID: 14522827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the procedures for high-yield expression and rapid purification of active recombinant Csk-homologous kinase (CHK): comparison of the catalytic activities of CHK and CSK.
    Chan KC; Lio DS; Dobson RC; Jarasrassamee B; Hossain MI; Roslee AK; Ia KK; Perugini MA; Cheng HC
    Protein Expr Purif; 2010 Dec; 74(2):139-47. PubMed ID: 20667476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Apr; 94():9-25. PubMed ID: 25662515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the substrate specificity determinants recognized by the active site of C-terminal Src kinase-homologous kinase (CHK) and identification of β-synuclein as a potential CHK physiological substrate.
    Ia KK; Jeschke GR; Deng Y; Kamaruddin MA; Williamson NA; Scanlon DB; Culvenor JG; Hossain MI; Purcell AW; Liu S; Zhu HJ; Catimel B; Turk BE; Cheng HC
    Biochemistry; 2011 Aug; 50(31):6667-77. PubMed ID: 21699177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
    Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
    J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated.
    Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB
    Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
    J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase.
    Ayrapetov MK; Lee S; Sun G
    Protein Expr Purif; 2003 Jun; 29(2):148-55. PubMed ID: 12767803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Src-family kinases in formation of the cortical actin cap at the dorsal cell surface.
    Kuga T; Hoshino M; Nakayama Y; Kasahara K; Ikeda K; Obata Y; Takahashi A; Higashiyama Y; Fukumoto Y; Yamaguchi N
    Exp Cell Res; 2008 Jun; 314(10):2040-54. PubMed ID: 18457834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk.
    Koegl M; Courtneidge SA; Superti-Furga G
    Oncogene; 1995 Dec; 11(11):2317-29. PubMed ID: 8570183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.